Profilo
Bradley J.
Powers is Chief Compliance Officer & General Counsel at Lumos Pharma, Inc. since 2020.
Formerly, Mr. Powers was Principal Executive Officer & General Counsel at NewLink Genetics Corp.
from 2019 to 2020 and General Counsel & Sales Director at KINZE Manufacturing, Inc. from 2013 to 2015.
Education includes undergraduate and graduate degrees from Iowa State University and a graduate degree from Drake University Law School.
Posizioni attive di Bradley Powers
| Società | Posizione | Inizio |
|---|---|---|
| LUMOS PHARMA, INC. | Responsabile della Conformità | 18/03/2020 |
Precedenti posizioni note di Bradley Powers
| Società | Posizione | Fine |
|---|---|---|
KINZE Manufacturing, Inc.
KINZE Manufacturing, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets planters and grain auger carts | Consigliere Generale | 01/08/2015 |
| LUMOS PHARMA, INC. | Amministratore Delegato | 18/03/2020 |
Formazione di Bradley Powers
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Iowa State University
Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KINZE Manufacturing, Inc.
KINZE Manufacturing, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets planters and grain auger carts | Producer Manufacturing |
Drake University Law School
Drake University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lumos Pharma, Inc.
Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
















